期刊文献+

甘精胰岛素与胰岛素泵对初诊2型糖尿病疗效对比分析 被引量:7

A comparative analysis of insulin glargine versus insulin pumps in recently diagnosed type 2 diabetes
下载PDF
导出
摘要 目的探讨甘精胰岛素、胰岛素泵持续皮下输注对初诊2型糖尿病患者的疗效。方法选择2007年1月至2010年3月180例初诊的2型糖尿病患者,随机分为3组,分别采用甘精胰岛素(A组)、胰岛素泵(B组)及常规口服降糖药物(C组)进行12周的治疗,检测治疗前后血糖、糖化血红蛋白(HbA1c)、胰岛素、C肽水平,计算β细胞功能(Homa-β)、胰岛素抵抗指数(Homa-IR)、血糖曲线下面积(AUCg)、胰岛素曲线下面积(AUCi),比较各项指标的变化。结果 3组患者治疗后血糖、HbA1c、Homa-IR、AUCg均较治疗前降低,胰岛素、C肽、Homa-β及AUCi均较治疗前升高,有显著性差异(P<0.01)。其中A组治疗前后HbA1c为(10.89±2.42)vs.(6.15±1.24),B组(11.42±2.31)vs.(6.23±1.29),C组(11.37±2.50)vs.(7.15±1.39);而A组治疗前后空腹胰岛素(7.14±1.24)μIU/mlvs.(10.03±1.67)μIU/ml,B组(7.20±1.42)μIU/mlvs.(10.34±1.65)μIU/ml,C组(7.01±1.38)μIU/mlvs.(8.94±1.51)μIU/ml。A、B组较C组改变更显著(P<0.05),A、B组间无显著性差异。结论甘精胰岛素和胰岛素泵持续皮下输注均能明显改善初诊2型糖尿病患者的胰岛β细胞功能。 Objective To compare the indexes variations of insulin glargine or insulin pump or oral hypoglycemic drugs in recently diagnosed type 2 diabetes.Methods A total of 180 individuals were randomly divided into three groups:insulin glargine(group A),insulin pumps(group B) and oral hypoglycemic drugs(group C) for 12 weeks respectively.The data of plasma glucose,glycosylated hemoglobin Alc(HbAlc),fasting insulin,C peptide,biochemistry index,function index of β-cell(Homa-β),insulin resistance index(Homa-IR) and area under curve of glucose and insulin before and after the therapy were compared.Results After 12 weeks' treatment,the plasma glucose,HbAlc,AUCg,Homa IR were significantly decreased,whereas insulin,C peptide,Homa-β and AUCi were significantly increased(P 0.01).HbA1c was decreased from(10.89±2.42)% to(6.15±1.24)%(in group A),(11.42±2.31)% to(6.23±1.29)%(in group B),(11.37±2.50)% to(7.15±1.39)%(in group C).And fasting insulin was increased from(7.14±1.24)μIU/mL to(10.03±1.67)μIU/mL(in group A),(7.20±1.42)μIU/mL to(10.34±1.65)μIU/mL(in group B),(7.01±1.38)μIU/mL(8.94±1.51)μIU/mL(in group C).Furthermore,there were more significant changes in group A and group B than group C(P 0.05),but there was no significant difference between group A and group B.Conclusions The β-cell function of patients with early stage of type 2 diabetes can be improved by use of insulin glargine or insulin pumps.
出处 《北京医学》 CAS 2011年第5期399-402,共4页 Beijing Medical Journal
关键词 2型糖尿病 甘精胰岛素 胰岛素泵 Type 2 diabetes Insulin glargine Insulin pump
  • 相关文献

参考文献8

二级参考文献25

共引文献60

同被引文献42

  • 1陆再英,钟南山.内科学[M].北京:人民卫生出版社,2009:493. 被引量:142
  • 2Brownlee M. The pathobiology of diabetic complications: a unify-ing mechanism[J]. Diabetes, 2005,54:1615-1625. 被引量:1
  • 3Kasznicki J, Kosmalski M,Sliwinska A,et al. Evaluation of oxi-dat-ive stress markers in pathogenesis of diabetic neuropathy [J],Mol Biol Rep, 2012,39:8669-8678. 被引量:1
  • 4Nourooz-Zadeh J, Ziegler D, Sohr C, et al. The use of pholasin asa probe for the determination of plasma total antioxidant capacity[J], Clin Biochem, 2006, 39:55-61. 被引量:1
  • 5Dordevic G,Duric S, Apostolskit S,et al. Total antioxidant bloodcapacity in patients with type 2 diabetes mellitus and distal sym-metrical polyneur- opathy[J]. Vojnosanit Pregl, 2008,65:663-669. 被引量:1
  • 6Pasaoglu H, Sancak B, Bukan N. Lipid peroxidation and resis-tance to oxidation in patients with type 2 diabetes mellitus[J]. To-hoku J Exp Med, 2004, 203:211-218. 被引量:1
  • 7Andrea M. Vincent, James W. Russell,Kelli A. Sullivan, et al.S0D2 protects neurons from injury in cell culture and ani-mal models of diabetic neuropathy [J]. Exp Neu-rol, 2007, 208:216-227. 被引量:1
  • 8Wiggin TD, Sullivan BCA, Pop -Busui R, et al. Elevated triglyc-erides correlate with progression of diabetic neuropathy [J]. Dia-betes, 2009, 58:1634-1640. 被引量:1
  • 9Bril V, Perkins BA. Validation of the Toronto Clinical ScoringSystem for diabetic polyneuropathy [J], DiabetesCare, 2002,25:2048-2052. 被引量:1
  • 10Gerich JE.Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes[J].Diabetes,2002,51(Suppl 1): 117-121. 被引量:1

引证文献7

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部